Ying-Fon Chang

Statistics

Publications

Citations

1.3K

H-Index

Active since

1992

Affiliations

Nivalis Therapeutics (United States)(Current)

University of Colorado Boulder

Ying-Fon Chang is an author at Nivalis Therapeutics (United States) specializing in molecular biology, aptamers, and aptamer - target binding affinity.

Publications per year

1992–2006

Publications

Tumor targeting by an aptamer.

Brian J. Hicke, Andrew Stephens, Ty Gould et al. · PubMed · 2006 · 383 citations

Medicine, Oncology, Pharmacology +17

Tenascin-C Aptamers Are Generated Using Tumor Cells and Purified Protein

Brian J. Hicke, C. Marion, Ying-Fon Chang et al. · Journal of Biological Chemistry · 2001 · 321 citations · Full text

Medicine, Cancer Biology, Oncology +14

Potent 2′-amino-, and 2′-fluoro-2′- deoxyribonucleotide RNA inhibitors of keratinocyte growth factor

Nikos Pagratis, Carol Bell, Ying-Fon Chang et al. · Nature Biotechnology · 1997 · 216 citations

Life Sciences, Molecular Biology, Pharmacology +4

DNA aptamers block L-selectin function in vivo. Inhibition of human lymphocyte trafficking in SCID mice.

Brian J. Hicke, Susan R. Watson, Andrea Koenig et al. · Journal of Clinical Investigation · 1996 · 132 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Calcium-dependent oligonucleotide antagonists specific for L-selectin.

D O'Connell, Andrea Koenig, Susan Jennings et al. · Proceedings of the National Academy of Sciences · 1996 · 111 citations · Full text

Pharmacy, Molecular Biology, Pharmacology +17

1–5 of 9